Nowadays hybrid imaging technologies play an important role in both translational research and clinical diagnostics by combining the modern equipment of radiology and nuclear medicine. Among routine diagnostic imaging procedures positron emission tomography (PET) and single photon emission computed tomography (SPECT) combined with computed tomography (CT) or magnetic resonance imaging (MRI) currently belong to the most advanced techniques in the world. With the aid of these modalities functional and morphological images can be superimposed on each other giving a new dimension to the field of diagnostics. Biochemical processes can be monitored that are essential for understanding and treating diseases or getting acquainted with the behavior of new drug candidates.
With the help of the clinical and preclinical non-invasive in vivo molecular imaging systems the drug development process can be shortened and its costs can be reduced.
At our imaging center, we pursue the mission to provide professional imaging solutions for translational research questions and to foster the progress from great ideas to real applications.